MedPath

Preoperative Evaluation of Lymph Nodes of Cholangiocarcinoma

Recruiting
Conditions
Intrahepatic Cholangiocarcinoma
Adenocarcinoma
Hilar Cholangiocarcinoma
Common Bile Duct Neoplasms
Cholangiocarcinoma
Interventions
Procedure: Endoscopic Ultrasound registration
Registration Number
NCT05678218
Lead Sponsor
Erasmus Medical Center
Brief Summary

The goal of this observational cohort study is to assess the yield of preoperative endoscopic ultrasound focussed on lymph nodes in patients with presumed resectable perihilar (pCCA), intrahepatic (iCCA) or mid-common bile duct (CBD) cholangiocarcinoma. The main questions it aims to answer is:

1. The number of patients precluded from surgical work-up due to positive regional or extraregional lymph nodes identified by endoscopic ultrasound guided tissue acquisition

2. Characteristics during endoscopic ultrasound of lymph nodes associated with malignancy

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
200
Inclusion Criteria
  • Presumed resectable pCCA OR
  • Presumed resectable iCCA OR
  • Presumed resectable mid-common bile duct CCA OR
  • Presumed unresectable pCCA worked-up for Liver Transplantation AND
  • Written informed consent must be given according to International Council on Harmonisation/Good Clinical Practice guidelines, and national/local regulations AND
  • Age > 18 years.
Read More
Exclusion Criteria
  • Patients with a history of treated CCA
  • Patients with CCA for which a pancreatoduodenectomy is indicated, based on cross-sectional imaging
  • Patients with a history of treated liver malignancy
  • Patients with a contra-indication for EUS-tissue acquisition (f.e. uncorrectable coagulopathy or platelet disorder), in line with current clinical practice
Read More

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
Presumed resectable perihilar, intrahepatic or mid-common bile duct (CBD) cholangiocarcinomaEndoscopic Ultrasound registration-
Primary Outcome Measures
NameTimeMethod
Lymph nodes identified compared to imagingThrough study completion, max 1 year

Number of lymph nodes correctly identified based on visualization and biopsy in comparison to cross-sectional imaging

Lymph nodes identified compared to surgeryThrough study completion, max 1 year

Number of lymph nodes correctly identified based on visualization and biopsy in comparison to surgery, in the patients in which this is performed

Secondary Outcome Measures
NameTimeMethod
Short term and long term complications of the EUS (+/- tissue acquisition) procedure for patients with pCCA and iCCAThrough study completion, max 1 year

Short term (\<30 days)

* Sedation related: consisting of cardiovascular-related complications (cardiac arrhythmias, myocardial ischemia/infarction), respiratory- related complications (respiratory depression, hypoxia, airway obstruction, pulmonary aspiration of gastric contents) and allergic reactions.

* Hemorrhage (outside peritoneal wall): defined as clinical evidence of bleeding with a hemoglobin drop of \>3g/dl with the need for resuscitation or additional intervention

* Perforation: defined as evidence of air or luminal contents outside the gastro-intestinal tract together with clinical symptoms, requiring percutaneous drainage or surgery

* Mortality

Long term (\>30 days)

- Tumor seeding; defined as proof of carcinoma in the biopsy tract during follow-up or at autopsy

Endoscopic Ultrasound (EUS)-characteristics predictive for malignant involvement of lymph nodesThrough study completion, max 1 year

Rate of malignant lymph nodes in which a certain characteristic is present (f.e. shape of the lymph node), in comparison to benign lymph nodes.

Different locations of positive lymph nodes and its effect on survivalThrough study completion, max 1 year

Days of survival after EUS and surgery, stratified per cholangiocarcinoma type, as well as lymph node locations

Trial Locations

Locations (7)

University Hospital of Ghent

🇧🇪

Ghent, Belgium

Amsterdam University Medical Center

🇳🇱

Amsterdam, Noord-Holland, Netherlands

Leiden University Medical Center

🇳🇱

Leiden, Zuid-Holland, Netherlands

Erasmus University Medical Center

🇳🇱

Rotterdam, Zuid-Holland, Netherlands

University Medical Center Groningen

🇳🇱

Groningen, Netherlands

Maastricht UMC+

🇳🇱

Maastricht, Limburg, Netherlands

University Medical Center Utrecht

🇳🇱

Utrecht, Netherlands

© Copyright 2025. All Rights Reserved by MedPath